News
-
AstraZeneca has announced positive top-line from the Phase 3 AMPLIFY study of the Duaklir aclidinium bromide/formoterol DPI in patients with moderate to very severe COPD. The study met its primary endpoints by demonstrating statistically significant… Read more . . .
-
Pulmatrix has announced a licensing agreement with Vectura for US development of Pulmatrix’s PUR0200 dry powder tiotropium formulation for the treatment of COPD. Vectura will pay Pulmatrix a $1 million “technology access fee” on achievement… Read more . . .
-
According to Pulmatrix, the Cystic Fibrosis Foundation Therapeutics (CFFT) will provide funds to support non-clinical development of PUR1900, an itraconazole DPI, for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis and asthma patients.… Read more . . .
-
Now that the Phase 3 CONVERT study has met its primary endpoint of culture conversion with statistical and clinical significance by Month 6, Insmed said, the company plans to seek priority review and accelerated approval… Read more . . .
-
Ascend Therapeutics is now promoting Egalet’s Sprix ketorolac tromethamine nasal spray for the treatment of moderate-to-moderately severe pain to women’s healthcare providers in the US, Egalet said. According to Egalet, the companies signed the agreement… Read more . . .
-
According to SmartInhaler maker Adherium, the FDA has granted 510(K) clearance for the company’s SmartTouch sensor for use with AstraZeneca’s Symbicort MDI. The SmartTouch device, which fits over the inhaler, records and transmits inhaler usage… Read more . . .
-
Device developer Coalesce Product Development has announced the appointments of Stephen Eason as Strategic Advisor and IP Consultant, and Mike Newton as Engineering Consultant. Both men have extensive experience in the development of OINDP devices.… Read more . . .
-
Dance Biopharm announced that it has bought back the Asia license for its Dance-501 soft mist inhaled insulin by purchasing the license holder, Harmony Biopharm Limited, from Harmony Plus Holdings Limited (Harmony). Dance said that… Read more . . .
-
RDD Online has announced that nominations are open for the 2018 Charles G. Thiel Award, and the committee will accept nominations through November 30, 2017. The award will be presented at RDD 2018, which will… Read more . . .
-
Acorda Therapeutics has received a refusal to file letter from the FDA in response to its NDA for Inbrija (CVT-301) inhaled levodopa for the treatment of OFF periods in Parkinson’s disease patients, the company said.… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA